TABLE 2: Characteristics of T. cruzi-HIV coinfection according to death status (survivors vs deceased).

Variables	Median (IQR) or n (%)		p-value (deceased vs survivors)
	Survivors (n=5)	Deceased (n=6)
Age at coinfection diagnosis, years	64 (48-66)	50.5 (46-58)	0.21
Sex
Men	3 (60.0)	1 (16.7)	0.24
Women	2 (40.0)	5 (83.3)
Race
White	1 (20.0)	4 (66.7)	0.24
Mixed	4 (80.0)	1 (16.7)	0.08
Black	0 (0.0)	1 (16.7)	1.00
Educational level
Illiterate	2 (40.0)	2 (33.3)	1.00
<9 years	2 (40.0)	4 (66.7)	0.57
>9 years	1 (20.0)	0 (0.0)	0.46
CD transmission mode
Vectorial	5 (100.0)	6 (100.0)	1.00
Time away from an endemic area
None	0 (0.0)	1 (16.7)	1.00
1-20 years	2 (40.0)	0 (0.0)	0.18
>20 years	3 (60.0)	5 (83.3)	0.55
Non-endemic area	0 (0.0)	0 (0.0)	1.00
HIV transmission mode
Unprotected heterosexual contact	3 (60.0)	5 (83.3)	0.54
Unprotected homosexual contact	1 (20.0)	1 (16.7)	1.00
Contaminated objects	1 (20.0)	0 (0.0)	0.46
Antiretroviral therapy (n=10)
No	0 (0.0)	2 (33.3)	0.47
Yes	4 (100.0)	4 (66.7)
CD4+ at HIV diagnosis	448.5 (133-831), n=4	350 (198-396.5), n=4	0.56
Viral load at HIV diagnosis	12500 (0-42051.5), n=4	1500 (399-300000), n=3	0.48
CD4+ <200 at coinfection diagnosis (n=8)
No	3 (75.0)	3 (75.0)	1.00
Yes	1 (25.0)	1 (25.0)
Time of coinfection diagnosis
Before 1997	0 (0.0)	2 (33.3)	0.46
After 1997	5 (100.0)	4 (66.7)
CD clinical form at coinfection diagnosis
Indeterminate	1 (20.0)	1 (16.7)	1.00
Cardiac	2 (40.0)	4 (66.7)	0.57
Digestive	1 (20.0)	1 (16.7)	1.00
Cardio-digestive	1 (20.0)	0 (0.0)	0.45
Classification of cardiac form at coinfection diagnosis (n=7)
Stage A	0 (0.0)	2 (50.0)	0.43
Stage B1	1 (33.3)	1 (25.0)	1.00
Stage B2	1 (33.3)	1 (25.0)	1.00
Stage C	1 (33.3)	0 (0.0)	0.43
Classification of digestive form at coinfection diagnosis (n=3)
Megaesophagus	0 (0.0)	1 (100.0)	0.33
Megacolon	0 (0.0)	0 (0.0)	1.00
Megaesophagus and megacolon	2 (100.0)	0 (0.0)	0.33
Qualitative xenodiagnosis at coinfection diagnosis (n=4)
Negative	0 (0.0)	0 (0.0)	---*
Positive	0 (0.0)	4 (100.0)
Quantitative xenodiagnosis at coinfection diagnosis (n=4)	---	16.3 (5-55.0)	---
Diagnosis of CD or HIV
CD first	2 (40.0)	4 (66.7)	0.57
HIV first	3 (60.0)	2 (33.3)
Comorbidities at coinfection diagnosis
Arterial hypertension	3 (60.0)	3 (50.0)	1.00
Diabetes mellitus	0 (0.0)	0 (0.0)	---*
Dyslipidemia	3 (60.0)	2 (33.3)	0.57
Hepatitis B	0 (0.0)	1 (16.7)	1.00
Non-Chagasic cardiomyopathy	0 (0.0)	0 (0.0)	---*
Antiparasitic drugs
No	4 (80.0)	1 (16.7)	0.08
Yes	1 (20.0)	5 (83.3)
High parasitemia under risk of reactivation (n=5)
No	0 (0.0)	3 (60.0)	---*
Yes	0 (0.0)	2 (40.0)
Clinical reactivation of CD
No	5 (100.0)	5 (83.3)	1.00
Yes	0 (0.0)	1 (16.7)

* p-value not calculated due to a lack of cases in the exposure or outcome categories.